Trial backs standard of care for rheumatic heart disease and atrial fibrillation - European Society of Cardiology
Notes to editor ESC Press Office Tel: +33 (0) 7 8531 2036 Email: press@escardio.org Follow us on Twitter @ESCardioNews The hashtag for ESC Congress 2022 is #ESCCongress. This press release accompanies both a presentation and an ESC press conference at ESC Congress 2022. It does not necessarily reflect the opinion of the European Society of Cardiology. Funding: INVICTUS was an investigator-initiated trial funded by an arm's length grant from Bayer AG to the Population Health Research Institute. Disclosures : None. References and notes 1 INVICTUS will be discussed during: 2 Roth GA, Mensah GA, Johnson CO, et al . Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study. J Am Coll Cardiol . 2020;76:2982–3021. 3 Zuhlke L, Karthikeyan G, Engel ME, et al . Clinical outcomes in 3343 children and adults with rheumatic heart disease From 14 low- and middle-income countries: Two-y